SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is capturing market attention following an $11.5 million defense contract and its selection as the U.S. Army's first qualified additive manufacturing vendor, intensifying community debates around its high volatility, significant short interest, and pivotal role in critical aerospace and defense applications.

Monster Beverage Corp. is a holding company, which engages in the development, marketing, sale, and distribution of energy drink beverages and concentrates. It operates through the following segments: Monster Energy Drinks, Strategic Brands, and Other. The Monster Energy Drinks segment sells ready-to-drink packaged energy drinks to bottlers and full-service beverage distributors. The Strategic Brands segment sells concentrates and beverage bases to authorized bottling and canning operations. The Other segment consists of certain products sold by its subsidiary, American Fruits and Flavors LLC to independent third-party customers. The company was founded on April 25, 1990, and is headquartered in Corona, CA.

Monster Beverage Corp.

Monster Beverage is a hot topic among investors who are weighing its consistent performance and strategic pricing power in a resilient energy drink market against concerns of stretched valuation and growing competition from rivals like Celsius. The community is actively discussing its ability to maintain strong margins and international growth, particularly as it approaches upcoming earnings.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is generating significant buzz following FDA approval for BYSANTI, a new treatment for bipolar I disorder and schizophrenia, as the community actively debates its potential for a major valuation rerating and speculates on a possible buyout driven by its extended patent protection and promising neuroscience pipeline.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Kennedy Space Center, FL.

Starfighters Space Inc

Starfighters Space (FJET) is trending as it prepares to ring the NYSE Opening Bell and participate in the upcoming 3rd Annual Space Summit, following successful wind tunnel testing for its STARLAUNCH I rocket with GE Aerospace. The community is actively discussing a potential short squeeze due to its tight float and a broader surge of interest in the space sector.

Okta, Inc. engages in the provision of an identity management platform for enterprises. It operates through the United States and International geographical segments. The firm's products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Okta is trending amidst intense community debate over how AI will impact cybersecurity, as some fear new AI security tools pose a threat while others see a massive growth opportunity for Okta's identity management in securing AI agents. This discussion follows a volatile reaction to its recent earnings, which, despite a beat and raise, initially saw a sell-off before renewed optimism sparked by analyst upgrades and a significant share buyback program.

Energizer Holdings, Inc. engages in the business of manufacturing, marketing, and distributing household batteries, specialty batteries, automotive appearance and performance products, refrigerants, air fresheners, and portable lights. The firm's portfolio of brands includes: Energizer, Armor All, Eveready, Rayovac, STP, Varta, A/C Pro, California Scents, Driven, Bahama & Co., LEXOL, Eagle One, Nu Finish, Scratch Doctor, and Tuff Stuff. It operates through the Battery and Lights, and Auto Care segments. The company was founded in 2000 and is headquartered in St. Louis, MO.

Energizer Holdings Inc

Energizer Holdings is trending due to recent positive earnings reports and an improved financial outlook that previously fueled a significant stock rally. However, discussions among investors remain divided, with ongoing concerns about organic sales challenges, margin pressures from tariffs, and competitive headwinds in its core consumer battery and auto care markets.

NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.

Neogenomics Inc.

NeoGenomics is seeing increased discussion after receiving a favorable court ruling in its patent lawsuit concerning the RaDaR technology. The community views this as a significant legal victory, removing a major hurdle and opening up substantial growth opportunities in the molecular residual disease monitoring market.

Global X Funds - Global X Social Media ETF

The Global X Social Media ETF ($SOCL) is trending due to recent strong performances and "monster breakouts" across its major social media holdings, prompting community discussion about the ETF "crushing it" and showing significant upward momentum.

Jack Henry & Associates, Inc. is a financial technology company, which engages in the provision of technology solutions and payment processing services. It operates through the following segments: Core, Payments, Complementary, and Corporate and Other. The Core segment provides core information processing platforms to banks and credit unions which consist of integrated applications required to process deposit, loan, and general ledger transactions, and maintain centralized customer and member information. The Payments segment includes secure payment processing tools and services including ATM, debit, and credit card processing services, online and mobile bill pay solutions, ACH origination and remote deposit capture processing, and risk management products and services. The Complementary segment focuses on additional software, hosted processing platforms, and services including call center support, network security management, consulting, and monitoring. The Corporate and Other segment offers hardware and other products. The company was founded by Jerry D. Hall and John W. Henry in 1976 and is headquartered in Monett, MO.

Jack Henry & Associates, Inc.

Jack Henry & Associates is trending after reporting stronger-than-expected earnings and raising its fiscal year guidance, which the community views as a positive signal for the financial software provider. Renewed investor interest focuses on the company's robust fintech solutions and ongoing modernization efforts within the banking sector.

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.

Phathom Pharmaceuticals Inc

The pricing of a significant public stock offering at a discount has intensified investor discussion around dilution and short activity for Phathom Pharmaceuticals. This occurs as the company reiterates its path to operating profitability by 2H26 for its GI treatment, Voquezna, following recent analyst upgrades and strong pre-released financial guidance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


guihangdilao

Gửi Hàng Đi Lào